CJC-1295 with DACis a synthetic growth hormone–releasing hormone (GHRH) analogue widely studied in peptide research involving endocrine signaling and hormone regulation pathways. This peptide is designed with aDrug Affinity Complex (DAC)modification, which extends its activity in experimental models by increasing peptide stability.
Researchers often investigate CJC-1295 with DAC in laboratory studies examining growth hormone signaling, metabolic processes, and endocrine system interactions.
Each vial fromPEPTIDE MEDICSis supplied inhigh-purity lyophilized formand available in2 mg and 5 mg research vialsfor controlled laboratory analysis.
All peptides sold byFubonzoare intendedstrictly for laboratory research purposes only.